Amgen Boosts Outlook Following Horizon Takeover, But Dips On Light Enbrel SalesInvestors Business Daily • 10/31/23
Amgen's stock jumps premarket after earnings beat and company again raises guidanceMarket Watch • 10/31/23
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain PatientThe Motley Fool • 10/30/23
Apple Headlines Earnings Calendar With Chip Titan AMD, Amgen Also Set To ReportInvestors Business Daily • 10/27/23
Amgen Inc. (AMGN) Amgen Conference Call Following European Society for Medical Oncology Congress 2023 TranscriptSeeking Alpha • 10/24/23
Amgen (AMGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 10/24/23
AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCERPRNewsWire • 10/22/23